Clinica    Scrip    RAJ    Scrip Clinical Research    Animal Pharm   
Welcome: IBI01 - Circulation
Home
Market Sector
Business
Policy & Regulation
Regions
News
|
Analysis
|
Features
|
MedTech Ventures
|
People
|
Events
|
Blog
|
Video & Podcasts
|
Science Abstracts
|
clinica
Imaging industry paints clear picture of NHS capital investment benefits
23 July 2010
Experts have highlighted the potential benefits of investing in advanced imaging equipment. They acknowledge that these systems can be expensive, but claim that they can reduce healthcare costs overall. At the time of going to press today, the ...
FDA continues crackdown on DTC genetic tests
23 July 2010
The FDA has sent warning letters to 13 molecular diagnostic companies as part of its bid to improve the regulation of genetic testing. The agency has targeted firms selling genetic tests directly to consumers, including Interleukin Health, CyGene ...
Roche repeats strong diagnostics performance in Q2
23 July 2010
Roche’s diagnostics division showed solid growth in Q2, continuing a positive performance so far in fiscal 2010. The diagnostic segment recorded SwFr5.25bn ($5.03bn) in sales, a 7% increase on a reported basis compared to the same period in ...
Bard adds breast care to offerings with $213m SenoRx buy
11 May 2010
CR Bard is to expand its peripheral vascular business beyond ultrasound-guided products with a definitive agreement to buy breast cancer diagnosis and treatment specialist SenoRx for $213m. For a cash consideration of $11 per share, Bard will gain ...
 
US transparency proposals may hurt device firms, industry warns
23 July 2010
The medtech industry has expressed concern over draft proposals from the US Food and Drug Administration to disclose to public information on medical devices and drugs that have not yet been approved. Disclosing information on pending device ...
FDA continues crackdown on DTC genetic tests
23 July 2010
The FDA has sent warning letters to 13 molecular diagnostic companies as part of its bid to improve the regulation of genetic testing. The agency has targeted firms selling genetic tests directly to consumers, including Interleukin Health, CyGene ...
Roche repeats strong diagnostics performance in Q2
23 July 2010
Roche’s diagnostics division showed solid growth in Q2, continuing a positive performance so far in fiscal 2010. The diagnostic segment recorded SwFr5.25bn ($5.03bn) in sales, a 7% increase on a reported basis compared to the same period in ...
Australian PIP implant surgery promises new insight into failures 11 May 2010

An Australian recipient of the controversial Poly Implant Prothèse (PIP) implants has undergone replacement surgery for the second time on the same breast in less than two months, Clinica has learnt. The first rupture occurred 14 weeks after ...

 
Abbott enjoys strong Q2 growth with vascular growth
23 July 2010
Abbott’s medtech division showed healthy growth in the second quarter with its vascular revenue showing particular strength. Vascular sales were up 27% on a reported basis to $835m. International sales of vascular products were up by around 52% to ...
Roche repeats strong diagnostics performance in Q2
23 July 2010
Roche’s diagnostics division showed solid growth in Q2, continuing a positive performance so far in fiscal 2010. The diagnostic segment recorded SwFr5.25bn ($5.03bn) in sales, a 7% increase on a reported basis compared to the same period in ...
St Jude builds momentum as Q2 prospers
23 July 2010
St Jude Medical has added to a positive fiscal performance in the first quarter of 2010 by reporting strong revenue gains and higher net income in Q2. The firm recorded sales of $1.31bn, an 11% improvement on the same period last year. This increase ...
ISCO and Cochlear to set up Indian operations
23 July 2010
The California, US-based biotechnology company, International Stem Cell Corporation (ISCO), and Cochlear of Australia, a firm specialising in hearing technology for the deaf, have announced plans to set up operations in India. They join a growing ...
 
Imaging industry paints clear picture of NHS capital investment benefits
23 July 2010
Experts have highlighted the potential benefits of investing in advanced imaging equipment. They acknowledge that these systems can be expensive, but claim that they can reduce healthcare costs overall. At the time of going to press today, the ...
Australian PIP implant surgery promises new insight into failures 11 May 2010

An Australian recipient of the controversial Poly Implant Prothèse (PIP) implants has undergone replacement surgery for the second time on the same breast in less than two months, Clinica has learnt. The first rupture occurred 14 weeks after ...

Italy extends deadline for top-ups to medtech promo duty
11 May 2010
Medical technology firms operating in Italy have been given extra time to top up the payment of duties that apply to "promotional activities" for 2009. The health ministry is allowing a one-month extension to account for discrepancies in monies or ...
Glaxo Novartis Non-WADA blood labs get chance to test in global anti-doping programme
11 May 2010
The World Anti-Doping Agency (WADA) has approved the use of non-accredited laboratories to conduct anti-doping blood testing under its Athlete Biological Passport Program. The decision announced by the executive committee following its 8-9 May ...
 
PEOPLE
"Pillar of scientific expertise" passes away Edward Arquilla, board member for in vitro diagnostic cancer test firm Radient Pharmaceuticals (RPC), has died. Dr Arquilla joined RPC in 1997 and ...
IDEV adds Donohoe for industry expertise Minimally-invasive medical device manufacturer IDEV Technologies has made industry veteran Dennis Donohoe its chief medical officer. Dr Donohoe has ...
Urologix adds Smrdel to management team Brian Smrdel has become the CFO of Urologix, a firm that specialises in minimally-invasive technology for treating benign prostatic hyperplasia. Mr ...
>> More People News...
The bell tolls for German health minister
30 June 2010
Faraz Kermani

There are those in this world who are clearly masters of their own destiny and those who are oracles of their own doom. German health minister Philip Rösler apparently has a foot in both camps. When he was catapulted into his post ahead of some of ...

 
The bell tolls for German health minister
30 June 2010
Faraz Kermani

There are those in this world who are clearly masters of their own destiny and those who are oracles of their own doom. German health minister Philip Rösler apparently has a foot in both camps. When he was catapulted into his post ahead of some of ...

Unexploited ways into the German market: why small is beautiful for medtech
25 February 2010
Dr Thomas Seeger

Changes to the way in which contracts are awarded for healthcare services in Germany are introducing a far greater element of flexibility. This offers an exciting new perspective, not only for payers and providers, but also for the medical device ...

Will device challenges transform the CAT into a lion?
25 February 2010
Amanda Maxwell

The Committee for Advanced Therapies (CAT) at the European Medicines Agency (EMA) is the first EU regulatory agency whose mission includes the automatic premarket assessment of Advanced Therapy Medicinal Products (ATMPs). The ATMP designation covers ...

 
Going global: medtech innovation amongst Norwegian companies
28 October 2009
Joseph Harvey

Norway has recently topped the United Nations human development index for 2009, making it the most “developed” country in the world. Surely this provides a background for strong medtech innovation? Joseph Harvey travelled to Oslo to meet with a ...

 
VIDEOS/PODCASTS
Optos' retinal scanning device
05 January 2010
Get the Flash Player to see this player.
 

Notified bodies: from 80 to just 10 by 2015?
02 October 2009
Amanda Maxwell

Notified body consolidation is likely to continue at a heavy pace over the next few years to the extent that only10 notified bodies or so will be operating in the medtech sector in five or so years time. That is the radical view of Martin de Bruin , ...

 
Patent Watch News alert tester
01 July 2010
Phil Greenfield

Clinica's Patent Watch looks at the previous month's most interesting patent applications. April's list of patent applications include a new method for treating spinal fractures with bone cement curable with radiofrequency energy, a rapid ...

 
Clinica's MedTech Ventures: Issue 36
28 October 2009

I recently visited Norway with senior business reporter Joseph Harvey to uncover some of the hidden medtech gems there. These were not too hard to find, considering that the country's public healthcare system – which is strongly supportive of ...

 
HUNT Biosciences
12 May 2010
Peter Rixon

Contact Information Halsanvegen 24 7600 Levanger Norway Tel: +47 951 24 048 or +47 951 24 048 Web: www.huntbiosciences.com Email: post@huntbiosciences.com Key Personnel Dr Per A Foss CEO Prof Kristian Hveem Chief scientific officer Håkon Haaheim ...

 
 
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Market Sector
Business
Policy & Regulation
Regions
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Clinica
Scrip
RAJ
Scrip Clinical Research
Animal Pharm